ReviewImmune network2025
VISTA: An Emerging Immune Checkpoint With Clinical Relevance Across Diverse Malignancies.
Hiba Laraki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewImmune network2025
Hiba Laraki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.